» Articles » PMID: 23907333

Frequency and Severity of Cirrhotic Cardiomyopathy and Its Possible Relationship with Bacterial Endotoxemia

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2013 Aug 3
PMID 23907333
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The cardiac dysfunction presented in cirrhotic patients is already known as cirrhotic cardiomyopathy. The pathogenesis of this entity is not fully understood.

Aims: The aim of this study was to evaluate the frequency and characteristics of cirrhotic cardiomyopathy and to investigate the possible role of bacterial endotoxemia on its aggravation.

Methods: Forty-five cirrhotics were studied by a tissue Doppler imaging echocardiography at rest and after stress. The diagnosis of left ventricular diastolic dysfunction was based on the latest guidelines of the American Society of Echocardiography, whereas its severity was defined by the E/e'av ratio. Endotoxemia was estimated by measuring the serum levels of lipopolysaccharide-binding protein (LBP) and cytokines.

Results: None of the patients had systolic dysfunction, but 17/45 (37.8 %) had a diastolic one. Patients with grade II diastolic dysfunction had significantly longer QTc (p = 0.049), larger left atrium volume (p = 0.013), higher Brain Natriuretic Peptide levels (p = 0.007) and higher LBP levels (p = 0.02), compared to those with normal cardiac function, without differences in the systemic hemodynamics and the cytokines' levels. Moreover, the severity of diastolic dysfunction as reflected by the E/e'av. was significantly correlated with the LBP levels (p = 0.002). On the multivariate analysis, the LBP was independently associated with the presence of diastolic dysfunction.

Conclusions: Cirrhosis is commonly complicated by cardiac dysfunction. Patients with severe cirrhotic cardiomyopathy have higher LBP levels, which are significantly correlated with the degree of diastolic dysfunction. Our findings support a potential role of bacterial endotoxemia on the aggravation of cardiomyopathy in cirrhotic patients.

Citing Articles

[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review: Part 1: definition, epidemiology, pathology and clinical manifestations].

Ramos H, Altieri M Rev Fac Cien Med Univ Nac Cordoba. 2024; 81(1):178-195.

PMID: 38537089 PMC: 11110665. DOI: 10.31053/1853.0605.v81.n1.44416.


Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?.

Wu H, Rakisheva A, Ponnusamy A, Chinnadurai R World J Gastroenterol. 2024; 30(2):128-136.

PMID: 38312119 PMC: 10835518. DOI: 10.3748/wjg.v30.i2.128.


B-Blockers in Liver Cirrhosis: A Wonder Drug for Every Stage of Portal Hypertension? A Narrative Review.

Karagiannakis D, Karakousis N, Androutsakos T Biomedicines. 2024; 12(1).

PMID: 38255164 PMC: 10813395. DOI: 10.3390/biomedicines12010057.


Prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria: alterations in ultrasonographic parameters of both left and right ventricles before and after stress.

Karagiannakis D, Stefanaki K, Anastasiadis G, Voulgaris T, Vlachogiannakos J Ann Gastroenterol. 2023; 36(5):564-572.

PMID: 37664234 PMC: 10433253. DOI: 10.20524/aog.2023.0824.


Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart.

Kalluru R, Gadde S, Chikatimalla R, Dasaradhan T, Koneti J, Cherukuri S Cureus. 2022; 14(8):e27969.

PMID: 36120195 PMC: 9467492. DOI: 10.7759/cureus.27969.


References
1.
Albillos A, de la Hera A, Gonzalez M, Moya J, Calleja J, Monserrat J . Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2002; 37(1):208-17. DOI: 10.1053/jhep.2003.50038. View

2.
Kleber G, Braillon A, Gaudin C, Champigneulle B, Cailmail S, Lebrec D . Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats. Gastroenterology. 1992; 103(1):282-8. DOI: 10.1016/0016-5085(92)91124-m. View

3.
Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M . Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology. 1999; 31(1):43-8. DOI: 10.1002/hep.510310109. View

4.
Guillo P, Mansourati J, Maheu B, Etienne Y, Provost K, Simon O . Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol. 1997; 79(9):1276-8. DOI: 10.1016/s0002-9149(97)00101-x. View

5.
Klein A, Burstow D, Tajik A, Zachariah P, Bailey K, Seward J . Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc. 1994; 69(3):212-24. DOI: 10.1016/s0025-6196(12)61059-3. View